A. Riis

1.1k total citations
10 papers, 804 citations indexed

About

A. Riis is a scholar working on Urology, Rheumatology and Molecular Biology. According to data from OpenAlex, A. Riis has authored 10 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Urology, 4 papers in Rheumatology and 3 papers in Molecular Biology. Recurrent topics in A. Riis's work include Urinary Bladder and Prostate Research (5 papers), Pelvic floor disorders treatments (3 papers) and Diabetes Management and Research (3 papers). A. Riis is often cited by papers focused on Urinary Bladder and Prostate Research (5 papers), Pelvic floor disorders treatments (3 papers) and Diabetes Management and Research (3 papers). A. Riis collaborates with scholars based in Denmark, Sweden and United Kingdom. A. Riis's co-authors include Anna Lindholm Olinder, Jens Peter Nørgaard, John McEwen, Philip Home, Lisbeth V. Jacobsen, Birgitte Søgaard, Åsa Rembratt, A. Cortesse, Joachim W. Thüroff and Philip Van Kerrebroeck and has published in prestigious journals such as Diabetes Care, European Urology and British Journal of Clinical Pharmacology.

In The Last Decade

A. Riis

10 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Riis Denmark 9 458 274 254 146 133 10 804
Jennifer Hall United States 14 154 0.3× 275 1.0× 65 0.3× 160 1.1× 43 0.3× 24 534
Timothy Moon United States 9 301 0.7× 112 0.4× 544 2.1× 193 1.3× 11 0.1× 10 762
Paul F. Engelhardt Austria 14 70 0.2× 144 0.5× 345 1.4× 209 1.4× 14 0.1× 35 596
Carlos Ary Vargas Souto Brazil 13 332 0.7× 116 0.4× 215 0.8× 53 0.4× 8 0.1× 26 612
Rahmi Onur Türkiye 15 38 0.1× 217 0.8× 412 1.6× 439 3.0× 24 0.2× 58 815
John B. Wear United States 13 40 0.1× 242 0.9× 128 0.5× 74 0.5× 51 0.4× 24 555
Supawadee Likitmaskul Thailand 16 377 0.8× 131 0.5× 17 0.1× 13 0.1× 180 1.4× 47 592
Amy Pearlman United States 10 243 0.5× 114 0.4× 111 0.4× 54 0.4× 10 0.1× 36 456
Nıhat Uluocak Türkiye 16 32 0.1× 208 0.8× 157 0.6× 89 0.6× 9 0.1× 54 483
Zeki Bayraktar Türkiye 11 54 0.1× 68 0.2× 84 0.3× 41 0.3× 14 0.1× 32 387

Countries citing papers authored by A. Riis

Since Specialization
Citations

This map shows the geographic impact of A. Riis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Riis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Riis more than expected).

Fields of papers citing papers by A. Riis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Riis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Riis. The network helps show where A. Riis may publish in the future.

Co-authorship network of co-authors of A. Riis

This figure shows the co-authorship network connecting the top 25 collaborators of A. Riis. A scholar is included among the top collaborators of A. Riis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Riis. A. Riis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kerrebroeck, Philip Van, Masoumeh Rezapour, A. Cortesse, et al.. (2007). Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study. European Urology. 52(1). 221–229. 104 indexed citations
2.
Lottmann, H., Frank M.J.A. Froeling, S. Alloussi, et al.. (2007). A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis. International Journal of Clinical Practice. 61(9). 1454–1460. 63 indexed citations
3.
Lottmann, H., et al.. (2006). A NEW ORAL MELT FORMULATION OF DESMOPRESSIN IN PRIMARY NOCTURNAL ENURESIS (PNE). A RANDOMISED COMPARISON TO THE TABLET FORMULATION. European Urology Supplements. 5(2). 303–303. 2 indexed citations
4.
Rembratt, Åsa, A. Riis, & Jens Peter Nørgaard. (2005). Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourology and Urodynamics. 25(2). 105–109. 91 indexed citations
5.
Hvistendahl, Gitte M., A. Riis, Jens Peter Nørgaard, & Jens Christian Djurhuus. (2005). The pharmacokinetics of 400 µg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect. British Journal of Urology. 95(6). 804–809. 15 indexed citations
6.
Agersø, Henrik, et al.. (2004). Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients. British Journal of Clinical Pharmacology. 58(4). 352–358. 58 indexed citations
7.
Robinson, Dudley, et al.. (2004). Antidiuresis: a new concept in managing female daytime urinary incontinence. British Journal of Urology. 93(7). 996–1000. 29 indexed citations
8.
Jacobsen, Lisbeth V., Birgitte Søgaard, & A. Riis. (2000). Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart. European Journal of Clinical Pharmacology. 56(5). 399–403. 97 indexed citations
10.
Olinder, Anna Lindholm, John McEwen, & A. Riis. (1999). Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.. Diabetes Care. 22(5). 801–805. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026